PROGRAM
Jul.24
Next-Generation Approaches in Drug Development
Room 402C, Hall 1
Date / Time :July 24 14:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402C)
Co-organizer: LumiSTAR Biotechnology, Molecular Devices
Time | Topic | Speaker |
---|---|---|
14:00-14:10 | Opening Remarks & Group Photo | Woolen Pan |
14:10-14:45 | Modernizing Drug Discovery: Innovative Human iPSC-Derived 3D Models as Animal Testing Alternatives | Yu-Fen Chang CEO and founder, LumiSTAR Biotechnology |
14:45-15:20 | Designing Microenvironments and Nanosurfaces for Controlling iPSCs and Their Application in Drug Screening and Regenerative Medicine | Li Liu CTO, EngiTissue Design |
15:20-15:40 | Tea Break & Networking | |
15:40-16:15 | Building Better Brain Drugs: Key Considerations in Early CNS Drug Discovery | Elsa Liu Technical Director, Eurofins Panlabs Discovery Services Taiwan |
16:15-16:50 | Leveraging High-Throughput Screening in Biomedical Research: From Principles to Practice | Ting-Jen Cheng |
16:50-17:00 | Closing Remarks | Yu-Fen Chang CEO and founder, LumiSTAR Biotechnology |
Jul.24
Treg Symposium 2025
Engineering Immune Peace: Translating Treg Science into Clinical Reality
Room 403, Hall 1
Date / Time : July 24 08:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 403)
Co-organizer : Taiwan Bio Therapeutics INC.
Time | Topic | Speaker |
---|---|---|
08:00-08:30 | Registration | |
08:30-09:00 | Opening Remarks | Session Chair: Cyrus Yang |
09:00-10:00 | Discovery of New Immunotherapy Targets and Mechanisms Leveraging CRISPR | Arlene H. Sharpe Kolokotrones University Professor|Harvard Medical School |
10:00-10:30 | Coffee Break | |
10:30-11:30 | Tfr Regulation of Antibody Mediated Diseases | Peter T. Sage Associate Professor of Medicine|Harvard Medical School and Brigham and Women's Hospital |
11:30-13:00 | Lunch Break | |
13:00-14:00 | Therapy in Autoimmunity with a Focus on Inflammatory Bowel Disease | William A. Faubion Dean of Research, MCA|Mayo Clinic Executive Medical Director, CRB|Mayo Clinic |
14:00-15:00 | Polymeric Particles for Immunomodulation | Jordan J. Green Herschel L. Seder Professor of Biomedical Engineering|Johns Hopkins University School of Medicine |
15:00-15:20 | Coffee Break | |
15:20-16:20 | Industry Perspective: Polyclonal Regulatory T Cell Therapy in Solid Organ Transplantation Clinical Trials |
Cyrus Yang |
16:20-17:00 | Panel Discussion & Concluding Remarks | Moderator: Cyrus Yang Panelists: Arlene H. Sharpe, Peter T. Sage, William A. Faubion, Jordan J. Green |
Jul.24
Promega Session-Innovating Biologics: Accelerating Drug Discovery and Development with Functional Bioassays
Room 503, Hall 1
Date / Time : July 24 13:00–17:30
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 503)
Co-organizer : Promega Corporation
Time | Topic | Speaker |
---|---|---|
13:00-13:30 |
Registration |
|
13:30 |
Opening |
LayPing Lee |
13:35-14:20 |
Illuminating Biologics Drug Discovery with Innovative Assays |
Dr. Frank Fan |
14:20-15:20 |
The Bioluminescent Toolbox for Vaccine Characterization and mRNA Quality Control |
Dr. Jamison Grailer |
15:20-15:50 |
Promega Bioassays: Enabling Reliable Methodology for Research and Industrial Advancement |
Dr. Mei-Wei Lin |
15:50-16:00 |
Break |
|
16:00-16:30 |
Bioassays Development for Product Release and Characterization - From a CDMO Perspective |
Dr. Toby Hong |
16:30-17:20 |
Bioluminescent Platform Technologies for Functional Characterization of Advanced Cancer Therapeutics |
Dr. Jamison Grailer |
17:20 |
Closing |
Dr. Frank Fan |
Jul.25
AI for Bio-Pharma Integrated Practice of Design, Quality, and Manufacturing
Room 402AB, Hall 1
Date / Time : July 25 14:00-17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 402AB)
Co-organizer: Genetics Generation Advancement Corp, Taiwan Bio Industry Organization
Time | Topic | Speaker |
---|---|---|
14:00-14:30 |
Guest Registration |
|
14:30-14:45 |
Opening Remarks |
|
14:45-15:15 |
Session 1 –Harnessing AI to Decode Bio Signatures: A New Frontier in Precision Drug Development |
Tsai, Keng-Chang Professor Lucas Nivon |
15:15-15:45 |
Session 2 – Accelerating Drug Innovation and Lab Automation through AI |
Peng Hua |
15:45-15:50 |
Q&A |
|
15:50-16:10 |
Session 3 – Leveraging AI-Driven Process Optimization to Transform Biopharmaceutical Manufacturing
|
Jack Lim |
16:10-17:00 |
AI Demo Time |
|
Session Synopsis:
As the global AI era unfolds, artificial intelligence is rapidly transforming the biopharmaceutical landscape—from drug design and quality control to manufacturing processes. This forum, themed “AI for Bio-Pharma Integrated Practice of Design, Quality, and Manufacturing”, will spotlight the multifaceted applications and successful use cases of AI in the biopharmaceutical industry.
We are honored to bring together leading experts from both Taiwan and abroad, including representatives from the National Research Institute Of Chinese Medicine, Dassault Systèmes, and MasterControl. Together, they will explore how AI is becoming a critical driving force in the industry, unlocking new potential and future opportunities.
The forum will feature three key topics:
Harnessing AI to Decode Bio Signatures: A New Frontier in Precision Drug Development
Accelerating Drug Innovation and Lab Automation through AI: Enhancing pharmaceutical quality management and process innovation
Leveraging AI-Driven Process Optimization to Transform Biopharmaceutical Manufacturing: How electronic batch records are reshaping manufacturing and quality systems
On behalf of the Bionet Group, we sincerely invite professionals from pharmaceutical companies, biotech firms, CRDMOs, and academic research institutions to join us for this insightful event.
Jul.25
Breaking into the U.S. Healthcare Innovation Market
Room 404, Hall 1
Jul.25
Digital and Automated Cell Manufacturing: From QbD to AI and Robotics
Room 503, Hall 1
Date / Time : July 25 13:30–17:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 503)
Co-organizer : Purple Win Co., Ltd.
Time | Topic | Speaker |
---|---|---|
13:30–14:00 |
Registration |
|
14:00–14:10 |
Opening Remarks |
Session Chair |
14:10–15:10 |
Advanced Morphological AI Analysis as a Process Analytical Technology for Quality by Design–Driven Process Development |
Ryuji Kato Associate Professor, Nagoya University, Tokai National Higher Education and Research System
|
15:10–15:30 |
Coffee Break |
|
15:30–15:40 |
2nd Opening Remark |
|
15:40–16:40 |
Development of robotic automation system for cell manufacturing |
Masahiro Kino-oka Professor, Department of Biotechnology, The University of Osaka
|
16:40–17:00 |
Closing Discussion |
Date / Time : July 26 09:00–12:00
Venue : Taipei Nangang Exhibition Center, Hall 1 (Room 401)
Co-organizer : Taiwan Biomedical Innovation Association, Taiwan Bio Industry Organization, NHRI Institute of Population Health Sciences
Language: Chinese only
Time | Topic | Speaker |
---|---|---|
09:00-09:20 |
Registration |
|
09:20-09:25 |
Opening Remarks |
Dr. Yun Yen Chairman, Taiwan Biomedical Innovation Association |
09:25-09:30 |
Special Address |
Dr. Huey-Herng Sheu
|
09:30-09:35 | Group Photo | |
09:35-10:00 |
Global trend of colorectal cancer by age, gender and risk factors |
Dr. Hung-Yi Chiou Director, NHRI Institute of Population Health Sciences |
10:00-10:25 |
Diabetes mellitus/hyperglycemia on colorectal cancer risk and oncological outcomes: from basic studies to clinical perspectives |
Dr. Jaw-Yuan Wang
|
10:25-10:40 |
Coffee Break |
|
10:40-11:05 | Evolution and Execution of Colorectal Treatment | Dr. Po-Li Wei Superintendent, Taipei Cancer Center, Taipei Medical University |
11:05-11:30 | Ovulation may promote carcinogenesis in the proximal colon | Dr. Tang-Yuan Chu Director, Center for Prevention and Therapy of Gynecological Cancers, Hualien Tzuchi General Hospital |
11:30-11:50 | Panel Discussion | Moderator: Dr. Yun Yen Panelists: Dr. Hung-Yi Chiou Dr. Jaw-Yuan Wang Dr. Po-Li Wei Dr. Tang-Yuan Chu |
11:50-12:00 | Kulia Labs' Demo | Winn Hong CEO, Kulia Labs |
12:00- | Closing Remarks | Dr. Yun Yen Chairman, Taiwan Biomedical Innovation Association |